🇺🇸 FDA
Patent

US 12103907

Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha

granted A61KA61K31/10A61K31/277

Quick answer

US patent 12103907 (Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha) held by Arcus Biosciences, Inc. expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arcus Biosciences, Inc.
Grant date
Tue Oct 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K31/10, A61K31/277, A61K31/343, A61K31/353